Why Ambry
Comprehensive testing for inherited neurological disorders, like intellectual disability, autism spectrum disorders, and epilepsy, can provide critical answers for patients and families. These can end the diagnostic search, avoid unnecessary and potentially invasive testing, and guide effective treatment. Ambry’s approach pairs a flexible, clinically driven test menu with a rigorous evidence base to help you identify at-risk patients and confidently determine management decisions with your neurology patients.
We strive to offer results that minimize ambiguity and uncertainty — standing behind our work with service and support, to ensure that the testing you choose yields clear, actionable insights to guide complex decisions in patient care.
Search Coverage by Genes
MOST FREQUENTLY ORDERED
Highlighted Neurology Tests
Highlighted Tests
GenomeNext™ and GenomeReveal™
Whole Genome
GenomeNext™ uses whole genome sequencing and advanced bioinformatics analysis to evaluate nuclear genes, mitochondrial DNA, and additional genomic regions beyond the coding regions assessed by exome sequencing.
Highlighted Tests
ExomeNext® and ExomeReveal®
Whole Exome
The world of genetics and our understanding of genetic causes for disease is rapidly changing. ExomeNext is a comprehensive test analyzing ~ 20,000 genes which has been successful in ending the diagnostic odyssey for…
Highlighted Tests
CustomNext-Neuro®
1537 Genes
Customizable panel that allows providers to select up to 500 genes from our neuro menu associated with intellectual disability, autism spectrum disorders, and/or epilepsy
Highlighted Tests
EpilepsyNext®
124 Genes
124 genes known to cause a variety of genetic epilepsies. Genes on this panel may have medical management implications.
Comprehensive Testing, Epilepsy Panels
CustomNext-Neuro®
1537 Genes
Customizable panel that allows providers to select up to 500 genes from our neuro menu associated with intellectual disability, autism spectrum disorders, and/or epilepsy
Comprehensive Testing, Epilepsy Panels
EpilepsyNext-Expanded®
965 Genes
>950 genes associated with causes of seizures primarily with neonatal to childhood onset
Comprehensive Testing, Epilepsy Panels
EpilepsyNext®
124 Genes
124 genes known to cause a variety of genetic epilepsies. Genes on this panel may have medical management implications.
Comprehensive Testing, Single Gene Test
AutismNext®
72 Genes
72 genes associated with non-syndromic autism and/or intellectual disability.
Comprehensive Testing, Single Gene Test
Fragile X-associated Disorders
1 Gene
Fragile X-associated disorders
Comprehensive Testing, Single Gene Test
NeurodevelopmentNext®
202 Genes
202 genes known to cause developmental delays, intellectual disability, and/or autism spectrum disorders
Single Gene Tests, Targeted Panels
Ataxia-telangiectasia (AT)
1 Gene
Ataxia-telangiectasia (AT)
Single Gene Tests, Targeted Panels
Hereditary hemorrhagic telangiectasia (HHT)
6 Genes
Most comprehensive panel for hereditary hemorrhagic telangiectasia (HHT)
Single Gene Tests, Targeted Panels
Li-Fraumeni syndrome
1 Gene
Li-Fraumeni syndrome
Single Gene Tests, Targeted Panels
Neurofibromatosis 2 (NF2)
1 Gene
Neurofibromatosis 2 (NF2)
Single Gene Tests, Targeted Panels
Nevoid basal cell carcinoma (Gorlin syndrome)
1 Gene
Nevoid basal cell carcinoma (Gorlin syndrome)
Single Gene Tests, Targeted Panels
Tuberous sclerosis complex (TSC)
2 Genes
Tuberous sclerosis complex (TSC)
Clinical Genomics
ExomeNext® and ExomeReveal®
Whole Exome
The world of genetics and our understanding of genetic causes for disease is rapidly changing. ExomeNext is a comprehensive test analyzing ~ 20,000 genes which has been successful in ending the diagnostic odyssey for…